Add like
Add dislike
Add to saved papers

Mpox whitlow: a novel presentation.

BACKGROUND: Mpox is a rare zoonotic disease with a progressive increase in cases among men who have sex with men (MSM) worldwide in the last months. New complications of this infection have been described.

OBJECTIVES AND METHODS: To describe this new pattern of presentation of Mpox at the level of the finger.

RESULTS: We present 3 cases of Mpox whitlow, a new clinical presentation of Mpox. The patients were 3 MSM with ages ranging from 32 to 49 years. All three had involvement of the third finger of the dominant hand as well as skin lesions at other sites. Two of the three patients had severe inflammation in the digit and proximal arm and were treated with systemic corticosteroids with significant improvement. In 2 of the 3 cases we observed onychodystrophy as a complication. All patients reported sexual intercourse with previous digital anal penetration with the affected finger, which may be the mode of transmission.

CONCLUSIONS: We describe three cases of this Mpox clinical presentation with some distinguishing features that need to be considered.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app